Showing results (1411-1420 of 3,156) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|January 29, 2014
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomasNesrin Sabha, Christiane B Knobbe, Majula Maganti, et al.
Neuro-Oncology|January 29, 2014
Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid TumorsEmmanuel Desandes, Sandra Guissou, Pascal Chastagner, et al.
Neuro-Oncology|January 29, 2014
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02Patrick Y Wen, Susan M Chang, Kathleen R Lamborn, et al.
Neuro-Oncology|October 24, 2012
The molecular biology of WHO grade I astrocytomasNicholas F Marko, Robert J Weil
Neuro-Oncology|February 9, 2022
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline gliomaEvan Cantor, Kyle Wierzbicki, Rohinton S Tarapore, et al.
Neuro-Oncology|January 14, 2014
mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannomaMarco Giovannini, Nicolas-Xavier Bonne, Jeremie Vitte, et al.
Neuro-Oncology|June 28, 2014
DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterationsDiego M Marzese, Richard A Scolyer, Maria Roqué, et al.
Neuro-Oncology|June 4, 2014
Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningiomaAyal A Aizer, Nils D Arvold, Paul Catalano, et al.
Neuro-Oncology|July 5, 2014
A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromesAdriaan H de Jongste, Teun van Gelder, Jacoline E Bromberg, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
Pageof 316